CEP
MLAB icon

Chicago Equity Partners’s Mesa Laboratories MLAB Stock Holding History

Chicago Equity Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,080
Closed -$970K – 921
2019
Q3 		$970K Buy
+4,080
New +$943K 0.05% 506

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Chicago Equity Partners's MLAB Position: Q4 2019 in Review

Chicago Equity Partners sold out of Mesa Laboratories (MLAB) in Q4 2019, closing a stake of 4,080 shares — an estimated $970K sold.

Chicago Equity Partners first reported a position in MLAB in Q3 2019 and held it in 1 quarter. The position peaked at $970K in Q3 2019. 151 funds tracked by Wall St. Rank hold MLAB as of Q4 2019.

  • Chicago Equity Partners reported no remaining Mesa Laboratories position as of Q4 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 4,080 Mesa Laboratories shares in Q4 2019, an estimated $970K.
  • Chicago Equity Partners first reported a position in Mesa Laboratories in Q3 2019 and held it in 1 quarter.
  • Chicago Equity Partners's Mesa Laboratories position peaked at $970K in Q3 2019.
  • 151 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2019.

Based on Chicago Equity Partners's 13F filing for Q4 2019, filed 10 Feb 2020.